From: A short tool to screen HIV-infected patients for mild neurocognitive disorders – a pilot study
Pathological screening test N = 17 | Normal screening test N = 13 | p-value | |||
---|---|---|---|---|---|
n | % | n | % | ||
Median Age, IQR | 55 | 49-64 | 49 | 43-61 | 0.201 |
Males | 15 | 88 | 11 | 85 | 0.591 |
Prior AIDS-defining condition | 6 | 35 | 5 | 38 | 0.579 |
Median CD4 cell count, IQR | 565 | 405-738 | 695 | 531-891 | 0.187 |
Median years of education, IQR | 12 | 11-13 | 13 | 12-13 | 0.336 |
cART containing efavirenz | 6 | 35 | 2 | 15 | 0.212 |
Co-medication with psychotropic drugs (antidepressants, antipsychotics) | 5 | 29 | 2 | 15 | 0.427 |
Memory loss or difficulties to concentrate reported by the patient* | 5 | 29 | 7 | 54 | 0.164 |
Depressive symptoms* | 2 | 12 | 1 | 8 | 0.603 |
Median duration of screening battery, minutes, IQR | 25 | 25-29 | 23 | 21-26 | 0.099 |